JANG, MYUNG HYUN,JUNG, SUNG YOUB,KWON, SE CHANG,PARK, YOUNG JIN,PARK, YOUNG KYUNG,SHEN, LING AI
申请号:
CA3064214
公开号:
CA3064214A1
申请日:
2012.06.07
申请国别(地区):
CA
年份:
2012
代理人:
摘要:
The present invention relates to a novel peptide showing more excellentactivities on aglucagon like peptide-1 receptor and a glucagon receptor than nativeoxyntomodulin, and acomposition for the prevention or treatment of obesity comprising the peptideas an activeingredient. Unlike native oxyntomodulin, the novel peptide of the presentinvention reduces foodintake, suppresses gastric emptying, and facilitates lipolysis with reducedside-effects, and alsoshows excellent receptor-activating effects. Thus, it can be widely used inthe treatment of obesitywith safety and efficacy.